MMM
3M CO
Healthcare • CIK: 0000066740
Loading...
Market Cap
$77.52B
P/E (TTM)
27.8x
Rev Growth (TTM)
+2.1%
Net Margin (TTM)
11.1%
FCF Yield (TTM)
2.7%
FCF Margin (TTM)
8.2%
Cash Flow Health
Free Cash Flow5/8 positive
TTM$2.1B
Q1 '26
$349M-74%
Q4 '25
$1.3B-13%
FCF Margin
TTM8.2%
Q1 '265.8%-73%
Sector: 0.0%Top 25%
OCF Margin11.8%
OCF/NI1.06x
CapEx Coverage3.3x
FCF Yield2.7%
FCF Growth (2Y)-20%
Cash Conversion Cycle
80 days
DSO: 54+DIO: 93−DPO: 67
Capital Allocation & Returns
Shareholder Friendly
Total Shareholder YieldTTM
TTM7.2%
Div Yield2.0%
+Buyback (TTM)5.1%
Strong capital returns to shareholders
Dividend & Payout Metrics
Dividend Yield (TTM)2.0%
FCF Payout Ratio76.6%
Free Cash Flow (TTM)$2.1B
Stock Repurchases (TTM)$4.0B
Capital Return / FCF269.6%
Est. Dividends Paid (TTM)$1.6B
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
16.3%
Stable
-0.0% YoY-2.0%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.2%
8Q: 16.8%
Asset Turnover
0.66x
8Q: 0.62x
Leverage (1+D/E)
4.85x
D/E: 3.85x
DuPont: 45.5% ≈ 16.3% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.46x
8Q:3.39x
+36.5%
Invested Cap Turn
1.15x
8Q:1.16x
+10.3%
CapEx Intensity
4.1%
8Q:4.4%
CapEx/Depreciation
0.67x
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $25.0B | $6.0B↓1.7% | $6.1B↓5.9% | $6.5B↑2.7% | $6.3B↑6.6% | $6.0B↓0.9% | $6.0B↓4.5% | $6.3B↑0.6% | $6.3B |
Operating Income | $4.8B | $1.4B↑75.5% | $796.0M↓45.0% | $1.4B↑26.9% | $1.1B↓8.5% | $1.2B↑14.8% | $1.1B↓17.6% | $1.3B↑3.5% | $1.3B |
Net Income | $2.8B | $653.0M↑13.2% | $577.0M↓30.8% | $834.0M↑15.4% | $723.0M↓35.2% | $1.1B↑53.3% | $728.0M↓46.9% | $1.4B↑19.8% | $1.1B |
Operating Cash Flow | $3.0B | $574.0M↓63.7% | $1.6B↓9.9% | $1.8B↑284.1% | $-954.0M↓1107.6% | $-79.0M↓104.3% | $1.8B↑201.7% | $-1.8B↓275.0% | $1.0B |
Free Cash Flow | $2.1B | $349.0M↓73.9% | $1.3B↓13.2% | $1.5B↑232.4% | $-1.2B↓268.9% | $-315.0M↓120.6% | $1.5B↑175.1% | $-2.0B↓370.3% | $752.0M |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
27.8x
Volatile
8Q: 97.9x+8320%
Multiple expansion without fundamental improvement
Valuation Lenses
Earnings
27.8x
vs – sector
Cash Flow
41.6x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
1.7P/E per %ROIC
ROIC: 16.3%
Shareholder Returns
Dividend
2.0%
Buyback
5.1%
Total Yield
7.2%
Market Cap$77.52B
EV$85.70B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
95/100
Exceptional
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Top 10%
63.8%
8Q:–
Return on Invested Capital (ROIC)Top 25%
16.3%
8Q:–
-2.0%
vs Sector:-0.0%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 14.2%
Asset Turnover: 0.66x
Earnings Quality
Cash Conversion
1.06x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin39.7%
Capital Efficiency
Invested Capital Turnover1.15x
Working Capital
Cash Conversion Cycle80 days
Growth Quality & Momentum
Low Quality
Growth Quality Score
42/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
2.1%
OpInc Growth YoY
12.1%
EPS Growth YoY
-34.5%
FCF 3Y CAGR
-20.2%
Growth Quality Analysis
⚠Working Capital Drag: FCF growth lagging revenue by 22.3%
⚠Sustainability Index: 3.0/10 - Growth sustainability concerns
Margin Quality & Sustainability
Low Quality
Profitability Cascade
Gross
39.7%
Operating
19.1%
Top 25% in sector
Net
11.1%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
-2.9 pts
FCF: 8.2% | Net: 11.1%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Leveraged
Net Debt / EBITDA
–Net Debt: $8.83B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
3.85x
Balance sheet risk & solvency analysis